Heinrich Scheiblauer

Author

Paul Ehrlich Institut ORCID

Also Known As

H Scheiblauer, H. Scheiblauer, Heinrich Scheiblauer

Publications

Citations

H-Index

Concepts

All Affiliations

Paul Ehrlich Institut Goethe University Frankfurt Charité - Universitätsmedizin Berlin Justus-Liebig-Universität Gießen Robert Koch Institute

About

Heinrich Scheiblauer is an author at Paul Ehrlich Institut specializing in medicine, virology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	182
2	Epidemiology	4	4	98
3	Immunology	3	3	52
4	Public Health	1	1	19
5	Hepatology	1	1	30

Heinrich Scheiblauer

Publications

976

Citations

H-Index

Page 1

	Year	Citations
Interactions between Bacteria and Influenza A Virus in the Developmentof Influenza Pneumonia Heinrich Scheiblauer, M. Reinacher, Masato Tashiro, The Journal of Infectious Diseases	1992	153
Performance evaluation of 70 hepatitis B virus (HBV) surface antigen (HBsAg) assays from around the world by a geographically diverse panel with an array of HBV genotypes and HBsAg subtypes Heinrich Scheiblauer, Mohamed El‐Nageh, Sonsoles Velázquez Díaz, Vox Sanguinis	2009	142
Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021 Heinrich Scheiblauer, Angela Filomena, Andreas Nitsche, Eurosurveillance	2021	133
Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Tatjana Scholz, Christine von Rhein, Imke Wieters, The Journal of Infectious Diseases	2020	81
Anti‐HBc screening of blood donors: a comparison of nine anti‐HBc tests Michael Schmidt, C. Micha Nübling, Heinrich Scheiblauer, Vox Sanguinis	2006	70
Hepatitis B virus genotype G monoinfection and its transmission by blood components Michael Chudy, Michael Schmidt, Volker Czudai, Hepatology	2006	59
Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design Heinrich Scheiblauer, C. Micha Nübling, Timo Wolf, Journal of Clinical Virology	2021	55
Pathogenicity of influenza A/Seal/Mass/1/80 virus mutants for mammalian species Heinrich Scheiblauer, Alan P. Kendal, R. Rott Archives of Virology Viral EvolutionMammalian SpeciesPathogenesisEmergent VirusVirology	1995	46
Evaluation of the performance of 44 assays used in countries with limited resources for the detection of antibodies to hepatitis C virus Heinrich Scheiblauer, Mohamed El‐Nageh, Sigrid Nick, Transfusion	2006	46
Effectiveness of blood donor screening by HIV, HCV, HBV‐NAT assays, as well as HBsAg and anti‐HBc immunoassays in Germany (2008–2015) Sarah Anna Fiedler, Doris Oberle, Michael Chudy, Vox Sanguinis	2019	39

Page 1